Tempest Therapeutics | 10.57 +0.55 +5.44% | ||
| TPST | |||
| 高 11.11 | 开 10.30 | 量 13.15万股 | 总市值 4693.25万 |
| 低 10.22 | 换 2.96% | 额 141.01万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Tempest Therapeutics(TPST)
08-12 04:15
$Tempest Therapeutics(TPST)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106558 Act: 34 Size: 7 MB 网页链接
Tempest Therapeutics(TPST)
08-12 04:15
$Tempest Therapeutics(TPST)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-106544 Act: 34 Size: 456 KB 网页链接
Tempest Therapeutics(TPST)
06-13 04:25
$Tempest Therapeutics(TPST)$ 8-K Current report, items 1.01, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-139899 Act: 34 Size: 529 KB 网页链接
Tempest Therapeutics(TPST)
06-07 04:15
$Tempest Therapeutics(TPST)$ 8-K Current report, item 5.02 Accession Number: 0001193125-25-137041 Act: 34 Size: 178 KB 网页链接
Tempest Therapeutics(TPST)
06-11 19:45
$Tempest Therapeutics(TPST)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-138802 Act: 34 Size: 175 KB 网页链接
Tempest Therapeutics(TPST)
06-12 21:05
$Tempest Therapeutics(TPST)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-139623 Act: 33 Size: 579 KB 网页链接
Tempest Therapeutics(TPST)
08-14 07:25
$Tempest Therapeutics(TPST)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000950170-25-108261 Act: 34 Size: 26 KB 网页链接